MedTrace Logo

Early Remote At-risk Diagnosis for Cerebral Palsy in Follow-up Clinics for High-risk Infants

NCT04287166 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-06-08

No results posted yet for this study

Summary

Cerebral Palsy (CP) is the most common motor dysfunction in childhood. Traditionally, diagnosis is set between 12 and 24 months of age. This study will evaluate feasibility of a new screening procedure for early detection of CP in high-risk infants and investigate how such a procedure can be implemented in the Central Norwegian Regional Health Authority (CNRHA).

The most accurate method to detect and predict CP at an early age is the General Movement Assessment (GMA). GMA is based upon expert observations of infant spontaneous movements in a video. In Central-Norway such expertise is today only present at St. Olavs Hospital, Trondheim University Hospital. Video recordings by health personnel and parents will be used in follow-up programs within CNRHA for remote expert based GMA. In addition, machine learning models will be applied for automatic detection of CP.

Early identification of CP will lead to improved function and increased possibility to direct health care resources to the patients who need it most, independent of geographical and expert based constraints.

Conditions

  • Cerebral Palsy

Sponsors & Collaborators

  • Alesund Hospital

    collaborator OTHER

  • Helse Nord-Trøndelag HF

    collaborator OTHER

  • St. Olavs Hospital

    lead OTHER

Principal Investigators

  • Lise Støylen · St Olavs Hospital, Clinic of Clinical Services

  • Torstein Rø IKOM · Norwegian University of Science and Technology, IKOM

Eligibility

Min Age
0 Months
Max Age
2 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-03
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04287166 on ClinicalTrials.gov